Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/07/2018
In a recently published study, treatment with EpiFix (MiMedx Group, Inc, Marietta, GA) was found to be more effective for wound closure than standard of care (SOC). The dehydrated human amnion/chorion membrane (dHACM) was compared in 2...
In a recently published study, treatment with EpiFix (MiMedx Group, Inc, Marietta, GA) was found to be more effective for wound closure than standard of care (SOC). The dehydrated human amnion/chorion membrane (dHACM) was compared in 2...
In a recently published study,...
09/07/2018
Today's Wound Clinic

Advertisement

News
08/15/2018
The MolecuLight i:X (MolecuLight Inc, Toronto, Ontario, Canada) received de novo clearance from the Food and Drug Administration, permitting expansion of the product into the United States market. The product is indicated as a handheld...
The MolecuLight i:X (MolecuLight Inc, Toronto, Ontario, Canada) received de novo clearance from the Food and Drug Administration, permitting expansion of the product into the United States market. The product is indicated as a handheld...
The MolecuLight i:X (MolecuLight...
08/15/2018
Today's Wound Clinic
News
08/15/2018
A recently published study has proposed a novel use for insect-spun silk: artificial skin and wound dressings. Researchers in Sweden and India combined the silk fibroin from silkworms and the silk proteins from spiders to create 2 types of...
A recently published study has proposed a novel use for insect-spun silk: artificial skin and wound dressings. Researchers in Sweden and India combined the silk fibroin from silkworms and the silk proteins from spiders to create 2 types of...
A recently published study has...
08/15/2018
Today's Wound Clinic
News
08/10/2018
Paratek Pharmaceuticals, Inc (Boston, MA), announced that the Antimicrobials Drug Advisory Committee of the Food and Drug Administration (FDA) approved the use of intravenous (IV) and oral omadacycline for the treatment of acute bacterial...
Paratek Pharmaceuticals, Inc (Boston, MA), announced that the Antimicrobials Drug Advisory Committee of the Food and Drug Administration (FDA) approved the use of intravenous (IV) and oral omadacycline for the treatment of acute bacterial...
Paratek Pharmaceuticals, Inc...
08/10/2018
Today's Wound Clinic

Advertisement

News
08/10/2018
Lumicell, Inc (Wellesley, MA), a company specializing in image-guided cancer surgery, announced its newest division in wound care, infection, and perfusion. The company looks to utilize its expertise in concurrent engineering to create...
Lumicell, Inc (Wellesley, MA), a company specializing in image-guided cancer surgery, announced its newest division in wound care, infection, and perfusion. The company looks to utilize its expertise in concurrent engineering to create...
Lumicell, Inc (Wellesley, MA), a...
08/10/2018
Today's Wound Clinic
News
08/09/2018
A new 1-ounce size of Prontosan Wound Gel X (B. Braun Medical, Inc, Bethlehem, PA) is now available in the United States market. This patient-friendly, smaller tube is a convenient and economical size for home care. Like the larger 250-mg...
A new 1-ounce size of Prontosan Wound Gel X (B. Braun Medical, Inc, Bethlehem, PA) is now available in the United States market. This patient-friendly, smaller tube is a convenient and economical size for home care. Like the larger 250-mg...
A new 1-ounce size of Prontosan...
08/09/2018
Today's Wound Clinic
News
08/08/2018
Acera Surgical (St Louis, MO) announced that it received a Federal Supply Schedule (FSS) contract from the National Acquisition Center of the Department of Veterans Affairs (Hines, IL). Effective until August 2023, the FSS contract allows...
Acera Surgical (St Louis, MO) announced that it received a Federal Supply Schedule (FSS) contract from the National Acquisition Center of the Department of Veterans Affairs (Hines, IL). Effective until August 2023, the FSS contract allows...
Acera Surgical (St Louis, MO)...
08/08/2018
Today's Wound Clinic

Advertisement

News
07/26/2018
The Centers for Medicare and Medicaid Services (CMS) has announced that it will not continue an experiment that saved millions of dollars by reducing nonemergent hyperbaric oxygen therapy (HBOT). Since launching in 2015, this experiment...
The Centers for Medicare and Medicaid Services (CMS) has announced that it will not continue an experiment that saved millions of dollars by reducing nonemergent hyperbaric oxygen therapy (HBOT). Since launching in 2015, this experiment...
The Centers for Medicare and...
07/26/2018
Today's Wound Clinic
News
07/24/2018
LAVIOR (Las Vegas, NV) introduced its new D-Care and W-Care ointments to the market for the care and management of chronic wound and inflammatory skin conditions. These ointments use a proprietary extract, AGS BOTANICAL, for an all-in-one...
LAVIOR (Las Vegas, NV) introduced its new D-Care and W-Care ointments to the market for the care and management of chronic wound and inflammatory skin conditions. These ointments use a proprietary extract, AGS BOTANICAL, for an all-in-one...
LAVIOR (Las Vegas, NV)...
07/24/2018
Today's Wound Clinic
News
07/24/2018
MyWoundDoctor, LLC (Nashville, TN), received the 2nd Place Prize and the AARP Audience Choice Award at the 2018 Northeastern University Nurse Innovation & Entrepreneurship Competition (Boston, MA). The telehealth wound care service provides...
MyWoundDoctor, LLC (Nashville, TN), received the 2nd Place Prize and the AARP Audience Choice Award at the 2018 Northeastern University Nurse Innovation & Entrepreneurship Competition (Boston, MA). The telehealth wound care service provides...
MyWoundDoctor, LLC (Nashville,...
07/24/2018
Today's Wound Clinic

Advertisement